Clinical trials
Observational Hypophosphatasia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 6 |
| Unknown status | 4 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alexion Pharmaceuticals, Inc. | 6 |
| Sheffield Teaching Hospitals NHS Foundation Trust | 3 |
| University of Bonn | 2 |
| AgNovos Healthcare, LLC | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| AstraZeneca | 1 |
| CENTOGENE GmbH Rostock | 1 |
| Children's Mercy Hospital Kansas City | 1 |
| Dr. Lothar Seefried | 1 |
| Duke University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypophosphatasia | 23 |
| Bone Diseases | 3 |
| Bone Diseases, Metabolic | 3 |
| Osteomalacia | 3 |
| Rare Diseases | 3 |
| Rickets | 3 |
| Cystinosis | 2 |
| Genetic Diseases, Inborn | 2 |
| Hyperargininemia | 2 |
| Leukodystrophy, Metachromatic | 2 |
Trials
Showing 26 to 23 of 23. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.